LivaNova Announces Marco Dolci, President of Cardiopulmonary, to Retire at the End of 2023
21 September 2023 - 1:00PM
Business Wire
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology
company, today announced that Marco Dolci intends to retire as
President of the Cardiopulmonary (CP) Business Unit (BU) by
December 31, 2023. Dolci will continue in his role and support the
transition of responsibilities through the end of the year. Franco
Poletti will serve as Interim General Manager of CP to support the
transition efforts, in addition to his current role as Vice
President of CP for Europe, effective immediately. LivaNova will
retain a leading international executive search firm to assist with
the search for a permanent successor for the President of CP.
“On behalf of the Board, the executive leadership team and the
employees at LivaNova, I would like to thank Marco for his
leadership over the last 6.5 years, especially during the
development and launch of the Essenz™ Perfusion System and during a
challenging time of market and supply chain disruption during and
post pandemic,” said Bill Kozy, Interim Chief Executive Officer and
Board Chair. “We wish Marco the best in his retirement from
LivaNova. We are confident in Franco and our experienced CP senior
leadership team and expect a smooth transition.”
Poletti joined LivaNova, then Sorin Group, in 1991. He brings a
depth of knowledge and experience in commercial strategy and
execution in the CP market. Poletti has led global and regional
divisions of the CP business and overseen various stages of product
development and launches. Plus, he has held leadership roles in the
Neuromodulation BU while at LivaNova.
About LivaNova
LivaNova PLC is a global medical technology company built on
nearly five decades of experience and a relentless commitment to
provide hope for patients and their families through medical
technologies, delivering life-changing improvements for both the
Head and Heart. Headquartered in London, LivaNova employs
approximately 2,900 employees and has a presence in more than 100
countries for the benefit of patients, healthcare professionals and
healthcare systems worldwide. For more information, please visit
www.livanova.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230920458015/en/
LivaNova Investor Relations and Media Contacts +1
281-895-2382 Briana Gotlin Director, Investor Relations
InvestorRelations@livanova.com Deanna Wilke VP, Corporate
Communications Corporate.Communications@livanova.com
LivaNova (NASDAQ:LIVN)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
LivaNova (NASDAQ:LIVN)
Historical Stock Chart
Von Mai 2023 bis Mai 2024